Iulia Murasan

Dr. Iulia Murasan

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SDStefania Diaconu
Stefania Diaconu
VMVlad Monescu
Vlad Monescu
RFRafaela Filip
Rafaela Filip
LILaura Irincu
Laura Irincu
CKCristian Kakucs
Cristian Kakucs
BOBianca Opritoiu
Bianca Opritoiu
Fatigue is a common non-motor symptom in Parkinson’s disease (PD), but even so, it may still be underdiagnosed or misdiagnosed in current practice due to its non-specific manifestations. The aims of this study were to investigate the prevalence of fatigue in PD patients compared to healthy controls and to identify the main characteristics and associations of fatigue with other non-motor symptoms and the impact of fatigue on sleep disturbances in Parkinson’s disease. Materials and methods: case–control study in which 131 PD patients and 131 age- and sex-matched controls were enrolled. Main characteristics of fatigue, sleep, and other non-motor symptoms were assessed using specific validated questionnaires. Results: According to the Chalder fatigue scale, fatigue is more prevalent in PD patients (38.16%) compared to healthy controls (26.71%). Fatigue was identified in 46.54% of the PD patients using the Parkinson’s Fatigue Scale (PFS-16). PD patients with fatigue presented a worse motor status, more sleep disturbances (insomnia, daytime sleepiness), a broader spectrum of non-motor symptoms (pain, anxiety, urinary disturbances), worse cognitive performances, a lower level of happiness, and worse quality of life compared to PD patients without fatigue. Conclusion: Fatigue is a common symptom of PD and needs to be assessed, considering its consequences on quality of life. Sleep disturbances have a great influence over fatigue in PD patients.

Verified
Journal Article
Open access
PDF file
Kallol (K) Chaudhuri also Ray-ChaudhuriKallol (K) Chaudhuri also Ray-Chaudhuri
Kallol (K) Chaudhuri also Ray-Chaudhuri
NTNataliya Titova
Nataliya Titova
MQMubasher A Qamar
Mubasher A Qamar
IMIulia Murasan
Iulia Murasan
Cristian Falup PecurariuCristian Falup Pecurariu
Cristian Falup Pecurariu
The vitals of Parkinson’s disease (PD) address the often-ignored symptoms, which are considered either peripheral to the central core of motor symptoms of PD or secondary symptoms, which, nevertheless, have a key role in the quality of life (QoL) and wellness of people with Parkinson’s (PwP)

2 September 2025 in Journal of Parkinson’s Disease
Verified
Journal Article
Open access
CFCristian Falup-Pecurariu
Cristian Falup-Pecurariu
LULarisa Ungureanu
Larisa Ungureanu
IMIulia Murasan
Iulia Murasan
SDStefania Diaconu
Stefania Diaconu
Sleep problems are among the most frequently reported non-motor symptoms of Parkinson's disease (PD), with a broad range of disorders: insomnia, REM sleep behavior disorder, restless legs syndrome, excessive daytime sleepiness, and sleep-related breathing disorders. These disturbances evolve in complexity across PD severity stages, significantly impact the patients’ quality of life and may exacerbate motor and other non-motor symptoms. Neurodegenerative processes, impaired function of neurotransmitters, medication side effects, circadian rhythm dysfunction are among the most proposed mechanisms that may explain the frequent occurrence of sleep disorders in PD. However, there are still many unanswered questions related to the pathophysiological mechanisms of sleep disorders in PD that may offer the clue to better therapeutical options. Although the prevalence of sleep disturbances is very high, the treatment options are still limited. The current review focuses on main sleep disturbances encountered in PD, pathophysiological insights, current therapeutical options and future perspectives for a better and more personalized management of these disorders in PD.

31 January 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
CFCristian Falup-Pecurariu
Cristian Falup-Pecurariu
IMIulia Murasan
Iulia Murasan
VMVlad Monescu
Vlad Monescu
CKCristian Kakucs
Cristian Kakucs
SDStefania Diaconu
Stefania Diaconu
Background: Non-motor symptoms in Parkinson’s disease (PD) consist of a wide spectrum of gastrointestinal impairment, urinary dysfunction, sleep disturbances, fatigue and psychiatric disorders. Mood disorders like anxiety and depression are linked to general well-being and overall quality of life, therefore influencing the amount and quality of restful sleep that the patients can achieve. Objectives: The aim of this study is to determine the prevalence and characteristics of anxiety and depression in PD and to identify the factors that correlate with sleep disturbances. Methods: We conducted a case–control study which included 131 PD patients and 131 controls. Descriptive data was collected, and validated scales and questionnaires regarding sleep, motor symptoms and symptoms related to anxiety and depression were administered. Patients were divided into groups by the presence or absence of sleep disorders (“bad sleepers” and “good sleepers”) and by the presence or absence of anxiety and depression. Comparative analysis was performed. Results: PD patients reported more clinically significant depression than controls and those with concomitant sleep impairment scored higher on depression- and anxiety-specific scales than their better-sleeping counterparts. Age, motor status and sleep impairment were found to be factors associated with depression in PD patients. The presence of sleep disorders was also associated with anxiety. Conclusions: Depression and anxiety are frequent in PD and are associated with comorbid sleep disturbances.

13 August 2026 in Movement Disorders
Verified
Journal Article
Open access
JKJaime Kulisevsky
Jaime Kulisevsky
LBLidia Bojtos
Lidia Bojtos
MKMilica Gregorič Kramberger
Milica Gregorič Kramberger
EMElisa Mantovani
Elisa Mantovani
IMIulia Murasan
Iulia Murasan
Cristian Falup PecurariuCristian Falup Pecurariu
Cristian Falup Pecurariu
Apathy is one of the most prevalent and disabling non‐motor symptoms in Parkinson's disease (PD) and dementia with Lewy bodies (DLB), collectively referred to as Lewy body disorders (LBDs). It is associated with reduced quality of life, accelerated cognitive decline, increased caregiver burden, and poorer functional outcomes, yet remains underrecognized and undertreated. A Working Group of the International Parkinson and Movement Disorder Society's Non‐Motor Symptoms Study Group conducted a comprehensive review of the literature and developed a position paper through iterative expert discussion and critical appraisal of available data. This review aims to provide a structured, expert‐informed synthesis of the current evidence on the clinical features, neurobiology, assessment, and management of apathy in LBDs and to define priorities for future research and clinical trials. Apathy in LBDs is a multidimensional syndrome encompassing reward insensitivity, negative affect, executive dysfunction, and auto‐activation deficits. Converging evidence implicates dysfunction within distributed frontal‐striatal‐limbic networks and multi‐neurotransmitter systems, including dopaminergic, serotonergic, noradrenergic, and cholinergic pathways. Although several pharmacological and nonpharmacological interventions have been explored, few randomized controlled trials have specifically targeted apathy, and no treatment can currently be considered definitively efficacious. Methodological heterogeneity, inadequate phenotyping, and inconsistent outcome measures have limited therapeutic progress. Apathy should be recognized as a primary clinical and research priority in LBDs. Future adequately powered, mechanistically informed trials using standardized diagnostic criteria and validated outcome measures are urgently needed to advance treatment development. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.